GlassScriptPhysician profile
Allyson J Martell
NPI 1306500517
$822.58
in general payments reported to CMS, 2019-2025
16 companies · $192 in 2025
The $192 reported for 2025 was more than what a typical Primary Care provider received nationally (typical 2025 total: $170).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $289 · 2023: $148 · 2024: $194 · 2025: $192.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $425 · Education: $108.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $425.47 |
| Education | $108.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $130.84 | 2022-2023 | Trulance, Xifaxan |
| Janssen Biotech, INC. | $118.61 | 2024-2025 | Erleada |
| Lilly USA, LLC | $115.85 | 2022-2025 | Jardiance, Jaypirca |
| Medtronic, INC. | $101.80 | 2022-2024 | Minimed 780g |
| Adaptive Biotechnologies Corporation | $78.73 | 2024-2025 | Clonoseq |
| Paratek Pharmaceuticals, INC. | $58.46 | 2022-2023 | Nuzyra |
| Glaxosmithkline, LLC. | $57.47 | 2022 | |
| Abbvie INC. | $32.07 | 2024 | |
| Rigel Pharmaceuticals, INC. | $17.87 | 2025 | Tavalisse |
| Exact Sciences Corporation | $17.65 | 2023 | Cologuard Collection Kit |
| Phadia US INC. | $17.57 | 2022 | |
| Currax Pharmaceuticals LLC | $17.50 | 2023 | Contrave |
| Genmab U.S., INC. | $15.20 | 2025 | Epkinly |
| Ultragenyx Pharmaceutical INC. | $14.79 | 2022 | |
| Pfizer INC. | $14.33 | 2023 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kite Pharma, INC. | $13.84 | 2025 | Yescarta |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Allyson Martell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.